These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 20506008)

  • 1. Heart rate response during vasodilator stress myocardial perfusion imaging: Mechanisms and implications.
    Hage FG; Iskandrian AE
    J Nucl Cardiol; 2010 Aug; 17(4):536-9. PubMed ID: 20506008
    [No Abstract]   [Full Text] [Related]  

  • 2. The impact of regimented aminophylline use on extracardiac radioisotope activity in patients undergoing regadenoson stress SPECT myocardial perfusion imaging: a substudy of the ASSUAGE trial.
    Ballany W; Mansour K; Morales Demori R; Al-Amoodi M; Doukky R
    J Nucl Cardiol; 2014 Jun; 21(3):496-502. PubMed ID: 24519563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regadenoson: a focused update.
    Ghimire G; Hage FG; Heo J; Iskandrian AE
    J Nucl Cardiol; 2013 Apr; 20(2):284-8. PubMed ID: 23229649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regadenoson for myocardial perfusion imaging: Is it safe?
    Hage FG
    J Nucl Cardiol; 2014 Oct; 21(5):871-6. PubMed ID: 24939324
    [No Abstract]   [Full Text] [Related]  

  • 5. Abnormal heart rate response with vasodilator stress myocardial perfusion imaging: Relevance to clinical practice.
    Dakik HA
    J Nucl Cardiol; 2017 Oct; 24(5):1672-1673. PubMed ID: 27272235
    [No Abstract]   [Full Text] [Related]  

  • 6. Adenosine-induced coronary vasospasm following drug-eluting stent implantation.
    Matsumoto N; Nagao K; Hirayama A; Kasama S
    BMJ Case Rep; 2014 Feb; 2014():. PubMed ID: 24518394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serious complications associated with regadenoson administration for myocardial perfusion imaging.
    Kitt T; Jiang J
    J Nucl Cardiol; 2015 Apr; 22(2):395. PubMed ID: 25548120
    [No Abstract]   [Full Text] [Related]  

  • 8. Trials and Tribulations of Assessing New Imaging Protocols: Combining Vasodilator Stress With Exercise.
    Davila CD; Udelson JE
    JACC Cardiovasc Imaging; 2018 Mar; 11(3):494-504. PubMed ID: 29519339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serious complications associated with regadenoson administration for myocardial perfusion imaging: a commentary.
    Hage FG; Iskandrian AE
    J Nucl Cardiol; 2014 Oct; 21(5):877-9. PubMed ID: 25156654
    [No Abstract]   [Full Text] [Related]  

  • 10. Experience of low-dose aminophylline use to relieve minor adverse effects of dipyridamole in patients undergoing stress myocardial perfusion imaging.
    Lin LF; Cheng CY; Hou CH; Ku CH; Tseng NC; Shen DH
    J Nucl Cardiol; 2014 Jun; 21(3):563-9. PubMed ID: 24627347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute myocardial infarction during adenosine myocardial perfusion imaging.
    Reyes E; Wechalekar K; Loong CY; Underwood SR
    J Nucl Cardiol; 2004; 11(1):97-9. PubMed ID: 14752479
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacologic stress testing: understanding the options.
    White MP
    J Nucl Cardiol; 1999; 6(6):672-5. PubMed ID: 10608596
    [No Abstract]   [Full Text] [Related]  

  • 13. The prognostic value of heart rate response during vasodilator stress myocardial perfusion imaging in patients with end-stage renal disease undergoing renal transplantation.
    AlJaroudi W; Anokwute C; Fughhi I; Campagnoli T; Wassouf M; Vij A; Kharouta M; Appis A; Ali A; Doukky R
    J Nucl Cardiol; 2019 Jun; 26(3):814-822. PubMed ID: 28924814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regadenoson-stress myocardial CT perfusion and single-photon emission CT: rationale, design, and acquisition methods of a prospective, multicenter, multivendor comparison.
    Cury RC; Kitt TM; Feaheny K; Akin J; George RT
    J Cardiovasc Comput Tomogr; 2014; 8(1):2-12. PubMed ID: 24314823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of heart rate response during regadenoson stress myocardial perfusion imaging in patients with end stage renal disease.
    AlJaroudi W; Campagnoli T; Fughhi I; Wassouf M; Ali A; Doukky R
    J Nucl Cardiol; 2016 Jun; 23(3):560-9. PubMed ID: 26293358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart rate response to vasodilator stress: A potential new application for a proven prognostic parameter.
    Schumann CL; Bourque JM
    J Nucl Cardiol; 2021 Dec; 28(6):2684-2686. PubMed ID: 32385831
    [No Abstract]   [Full Text] [Related]  

  • 17. Sex and age differences in the association of heart rate responses to adenosine and myocardial ischemia in patients undergoing myocardial perfusion imaging.
    Gebhard C; Messerli M; Lohmann C; Treyer V; Bengs S; Benz DC; Giannopoulos AA; Kudura K; von Felten E; Schwyzer M; Gaemperli O; Gräni C; Pazhenkottil AP; Buechel RR; Kaufmann PA
    J Nucl Cardiol; 2020 Feb; 27(1):159-170. PubMed ID: 29687292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of ultra low-dose thallium myocardial perfusion protocol using CZT SPECT.
    Bednárová V; Kincl V; Kamínek M; Vašina J; Panovský R; Máchal J
    Int J Cardiovasc Imaging; 2019 Jun; 35(6):1163-1167. PubMed ID: 30680654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic value of non-perfusion variables obtained during vasodilator stress myocardial perfusion imaging.
    Bajaj NS; Singh S; Farag A; El-Hajj S; Heo J; Iskandrian AE; Hage FG
    J Nucl Cardiol; 2016 Jun; 23(3):390-413. PubMed ID: 26940574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies for defining an optimal risk-benefit ratio for stress myocardial perfusion SPECT.
    Fazel R; Dilsizian V; Einstein AJ; Ficaro EP; Henzlova M; Shaw LJ
    J Nucl Cardiol; 2011 May; 18(3):385-92. PubMed ID: 21432002
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.